# FDA Inspection 1031302 - Southwest Transplant Alliance, Inc. - November 06, 2017

Source: https://www.keypedia.com/records/fda_inspections/southwest-transplant-alliance-inc/78d47d99-1ff4-4dee-a3fd-fdccc091d71c
Source feed: FDA_Inspections

> FDA Inspection 1031302 for Southwest Transplant Alliance, Inc. on November 06, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031302
- Company Name: Southwest Transplant Alliance, Inc.
- Inspection Date: 2017-11-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1294894 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/southwest-transplant-alliance-inc/e011a377-abe5-4389-a194-96a740e4f53f)
- [FDA Inspection 1294894 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/southwest-transplant-alliance-inc/dc137d03-3d41-4385-b807-99eecfde9014)
- [FDA Inspection 1196522 - 2023-02-03](https://www.keypedia.com/records/fda_inspections/southwest-transplant-alliance-inc/6265b8ab-4b0f-4ae4-9061-a38cd20db8b4)
- [FDA Inspection 1196522 - 2023-02-03](https://www.keypedia.com/records/fda_inspections/southwest-transplant-alliance-inc/d0305759-c5aa-4836-b180-33580f6468ad)

Company: https://www.keypedia.com/companies/southwest-transplant-alliance-inc/305df417-381d-4af1-acf2-1dd12504b57c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d